Picture of Syndax Pharmaceuticals logo

SNDX — Syndax Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSucker Stock

Syndax Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary

* Syndax Pharmaceuticals Inc  SNDX.OQ  reported a quarterly
adjusted loss of 98 cents​​ per share for the quarter ended
September 30, lower than the same quarter last year, when the
company reported EPS of -73 cents.  The mean expectation of
thirteen analysts for the quarter was for a loss of $1.11 per
share. Wall Street expected results to range from $-1.26 to -82
cents per share.
    * Revenue was $12.50 million​; analysts expected $11.20
million. 
    * Syndax Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 98 cents​.
    * The company reported a quarterly loss of $84.13 million.
    * Syndax Pharmaceuticals Inc shares had fallen by 1.6% this
quarter and lost 12.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.4%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 14 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Syndax
Pharmaceuticals Inc is 35.00 
This summary was machine generated from LSEG data November 6 at
04:44 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -1.11          -0.98          Beat
 Jun. 30 2024      -0.91          -0.80          Beat
 Mar. 31 2024      -0.98          -0.85          Beat
 Dec. 31 2023      -0.99          -1.00          Missed

Recent news on Syndax Pharmaceuticals

See all news